Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TESARO Inc (NASDAQ:TSRO)

43.22
Delayed Data
As of Jun 24
 -1.95 / -4.32%
Today’s Change
29.51
Today|||52-Week Range
66.95
-17.39%
Year-to-Date
Is Opko Health a Buy Now That Rayaldee Is Approved?
Jun 21 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close45.17
Today’s open42.86
Day’s range42.19 - 44.85
Volume728,985
Average volume (3 months)588,631
Market cap$2.0B
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-33.19%
Earnings growth (this year)-10.61%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales6,500.72
Price/Book20.04

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV-2.93-5.42%
RAREUltragenyx Pharmaceu...-2.78-5.35%
MYGNMyriad Genetics Inc-0.76-2.47%
GWPHGW Pharmaceuticals P...-5.83-6.54%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)-$1.66
Annual revenue (last year)$317.0K
Annual profit (last year)-$251.4M
Net profit margin-79,308.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Leon O. Moulder
President, Chief Operating Officer &
Director
Mary Lynne Hedley
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs